INmune Bio, Inc. Announces Pre-Clinical Data That Support a Pioneering Approach to Treating Duchenne Muscular Dystrophy January 25, 2023
First Wave BioPharma Announces Expansion of Adrulipase Intellectual Property Portfolio January 25, 2023
Qualigen Therapeutics Initiates Good Laboratory Practice (GLP) Toxicology Studies on QN-302 January 24, 2023